ValuEngine upgraded shares of Select Medical (NYSE:SEM) from a hold rating to a buy rating in a research note released on Friday morning.
A number of other equities analysts also recently weighed in on the company. Zacks Investment Research downgraded Select Medical from a hold rating to a sell rating in a research report on Wednesday, December 13th. Robert W. Baird set a $25.00 price target on Select Medical and gave the stock a buy rating in a research report on Monday, October 23rd. Bank of America raised Select Medical from an underperform rating to a neutral rating and set a $19.00 price target for the company in a research report on Thursday, January 4th. Deutsche Bank reaffirmed a buy rating and set a $22.00 price target on shares of Select Medical in a research report on Monday, November 6th. Finally, Royal Bank of Canada reaffirmed a buy rating and set a $19.00 price target on shares of Select Medical in a research report on Friday, October 13th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and six have issued a buy rating to the company’s stock. Select Medical presently has an average rating of Hold and an average price target of $20.25.
Select Medical (NYSE:SEM) opened at $16.30 on Friday. Select Medical has a 12-month low of $12.00 and a 12-month high of $19.77. The company has a debt-to-equity ratio of 3.36, a quick ratio of 1.51 and a current ratio of 1.51. The firm has a market capitalization of $2,180.00, a P/E ratio of 22.64, a price-to-earnings-growth ratio of 1.10 and a beta of 1.30.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. PNC Financial Services Group Inc. boosted its holdings in shares of Select Medical by 4.8% in the 2nd quarter. PNC Financial Services Group Inc. now owns 8,709 shares of the health services provider’s stock valued at $133,000 after buying an additional 396 shares during the last quarter. Flinton Capital Management LLC boosted its holdings in shares of Select Medical by 75.8% in the 2nd quarter. Flinton Capital Management LLC now owns 9,744 shares of the health services provider’s stock valued at $150,000 after buying an additional 4,200 shares during the last quarter. Eqis Capital Management Inc. acquired a new stake in shares of Select Medical in the 3rd quarter valued at approximately $201,000. Shelton Capital Management acquired a new stake in shares of Select Medical in the 2nd quarter valued at approximately $164,000. Finally, Macquarie Group Ltd. acquired a new stake in shares of Select Medical in the 3rd quarter valued at approximately $265,000. 77.87% of the stock is owned by institutional investors.
WARNING: This piece was first reported by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark legislation. The correct version of this piece can be accessed at https://sportsperspectives.com/2018/02/06/select-medical-sem-lifted-to-buy-at-valuengine.html.
About Select Medical
Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company’s segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.